Related Experiment Video

Updated: May 26, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through

Ludovica Ciuffreda1, Cristina Di Sanza, Ursula Cesta Incani

  • 1Division of Medical Oncology A, Laboratory of Experimental Preclinical Chemotherapy and Translational Oncogenomics, Regina Elena National Cancer Institute, Chianesi, n. 53, 00144, Rome, Italy.

Journal of Molecular Medicine (Berlin, Germany)
|January 5, 2012
PubMed

Insights

Simultaneous MEK and mTOR inhibition shows complex effects in melanoma. MEK inhibition alone can upregulate PTEN, enhancing antitumor activity and reducing the need for combined blockade.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling Pathways

Background:

  • Mitogen-activated protein kinase (MAPK) and PI3K pathways are crucial in cancer and exhibit significant crosstalk.
  • Tumor cells often exploit pathway crosstalk as an escape mechanism, prompting investigation into combined pathway inhibition.
  • Previous strategies suggested dual pathway blockade could yield synergistic antitumor effects.

Purpose of the Study:

  • To investigate the effects of simultaneous MEK and mammalian target of rapamycin (mTOR) inhibition in a melanoma model.
  • To identify novel crosstalk mechanisms between MAPK and PI3K pathways in cancer.
  • To elucidate the role of phosphatase and tensin homolog (PTEN) in mediating MEK inhibitor efficacy.

Main Methods:

  • Utilized the M14 melanoma cell line for in vitro and in vivo experiments.
  • Administered pharmacologic and genetic inhibition of MEK signaling.
  • Assessed downstream signaling through AKT and mTOR, and measured PTEN expression.
  • Investigated MAPK-dependent regulation involving c-Jun and miR-25.

Main Results:

  • Simultaneous MEK and mTOR inhibition demonstrated synergistic effects at suboptimal doses but antagonism at high MEK inhibitor concentrations.
  • MEK inhibition, pharmacologically or genetically, led to restored PTEN expression, inhibiting AKT/mTOR signaling.
  • PTEN upregulation was identified as a key mediator of MEK inhibitors' antitumor effects, with PTEN-deficient cells showing resistance.

Conclusions:

  • A novel crosstalk mechanism exists where MEK inhibition upregulates PTEN, potentially bypassing the need for combined pathway blockade.
  • PTEN status is critical for determining cancer cell sensitivity to MEK inhibitors.
  • Understanding this PTEN-mediated regulation is crucial for optimizing MEK inhibitor-based cancer therapies.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...